Aug
03
2020
Minerva Neurosciences Reports Second Quarter 2020 Financial Results and Business Updates
(GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, …